Traditionally, developing a new drug can take over a decade, but AI technology is changing that timeline. Major pharmaceutical companies like Pfizer and AstraZeneca are leveraging AI to accelerate the ...

Researchers at the University created an AI model called EZSpecificity to test how certain enzymes and substrates bind to ...

The FDA approved a drug made by Kura Oncology to treat patients with a certain type of genetically altered leukemia.

The pharmaceutical industry widely uses antibodies to create drugs, such as for cancer and coronaviruses. But creating the ...

Lantern Pharma Inc. (NASDAQ:LTRN) is set to showcase two of its commercially deployed artificial intelligence platforms at the University of North Texas’ inaugural AI for Biology and Medicine (AI4BM) ...

At AAPS PharmSci 360 2025, held from Nov. 9–12 in San Antonio, Texas, Corey Bloom, PhD, associate director, CMC (chemistry, ...

Developing high-quality, safe, and effective drugs is a complex process that requires varied scientific skills and stringent regulatory assessments. Drug development is a process that spans many years ...

Glucagon-like peptide agonists (GLP-1s, like Ozempic, Wegovy, and Mounjaro) have been hailed as breakthroughs. From statins to Viagra, occasionally a drug development breakthrough occurs that is ...

The Congressional Budget Office (CBO) informs Congress about the costs or revenue changes associated with proposed legislation, a challenging enough task on its own. Sometimes, the CBO is asked to ...

Pfizer noted it has completed its acquisition of all outstanding shares of the company’s common stock for $65.60 per share in ...

What does Rick Pazdur's new role mean for the FDA? And how much credit can the president take for lowering GLP-1 drug prices?

President Donald Trump deserves much of the credit for these pricing decisions. For months, he has been demanding that ...